CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 24,248 shares at $24.79 ($601,108)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 22,000 shares at an average $26.32 ($578,966)
- 10-Q Report Quarterly Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 15-15D/A Other 15-15D/A
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- EFFECT Other Notice of Effectiveness
- 15-15D Other 15-15D
- S-3 Offering Registration Statement
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
Page 16 of 39 · 778 filings